These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 27880669)

  • 1. Conclusion and future perspectives on antifungal stewardship.
    Aguado JM; Silva JT; Bouza E
    J Antimicrob Chemother; 2016 Nov; 71(suppl 2):ii43-ii44. PubMed ID: 27880669
    [No Abstract]   [Full Text] [Related]  

  • 2. Mitigation of human-pathogenic fungi that exhibit resistance to medical agents: can clinical antifungal stewardship help?
    Hull CM; Purdy NJ; Moody SC
    Future Microbiol; 2014; 9(3):307-25. PubMed ID: 24762306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strategies in the discovery of novel antifungal scaffolds.
    Liu N; Wang C; Su H; Zhang W; Sheng C
    Future Med Chem; 2016 Aug; 8(12):1435-54. PubMed ID: 27463376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current recommendations and importance of antifungal stewardship for the management of invasive candidiasis.
    Miyazaki T; Kohno S
    Expert Rev Anti Infect Ther; 2015; 13(9):1171-83. PubMed ID: 26089168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Invasive Fungal Infections in Patients with Hematological Malignancies: Emergence of Resistant Pathogens and New Antifungal Therapies.
    Gamaletsou MN; Walsh TJ; Sipsas NV
    Turk J Haematol; 2018 Mar; 35(1):1-11. PubMed ID: 29391334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of antifungal agent resistance.
    Yang YL; Lo HJ
    J Microbiol Immunol Infect; 2001 Jun; 34(2):79-86. PubMed ID: 11456364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resistance to antifungal therapies.
    Prasad R; Banerjee A; Shah AH
    Essays Biochem; 2017 Feb; 61(1):157-166. PubMed ID: 28258238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiology of antifungal resistance in human pathogenic yeasts: current viewpoint and practical recommendations for management.
    Farmakiotis D; Kontoyiannis DP
    Int J Antimicrob Agents; 2017 Sep; 50(3):318-324. PubMed ID: 28669831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Editorial: Resistance to antifungal agents.
    Odds FC
    Fungal Genet Biol; 2010 Feb; 47(2):190. PubMed ID: 20026235
    [No Abstract]   [Full Text] [Related]  

  • 10. Antifungal drug resistance mechanisms in fungal pathogens from the perspective of transcriptional gene regulation.
    Sanglard D; Coste A; Ferrari S
    FEMS Yeast Res; 2009 Oct; 9(7):1029-50. PubMed ID: 19799636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular Evolution of Antifungal Drug Resistance.
    Robbins N; Caplan T; Cowen LE
    Annu Rev Microbiol; 2017 Sep; 71():753-775. PubMed ID: 28886681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Responding to the emergence of antifungal drug resistance: perspectives from the bench and the bedside.
    Beardsley J; Halliday CL; Chen SC; Sorrell TC
    Future Microbiol; 2018 Aug; 13(10):1175-1191. PubMed ID: 30113223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The global problem of antifungal resistance: prevalence, mechanisms, and management.
    Perlin DS; Rautemaa-Richardson R; Alastruey-Izquierdo A
    Lancet Infect Dis; 2017 Dec; 17(12):e383-e392. PubMed ID: 28774698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The future of fungal susceptibility testing.
    Posteraro B; Sanguinetti M
    Future Microbiol; 2014; 9(8):947-67. PubMed ID: 25302953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Latest trends in fungal epidemiology inform treatment choices and stewardship initiatives.
    Sinkó J; Bryan J
    Future Microbiol; 2012 Oct; 7(10):1141-6. PubMed ID: 23030421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antifungal resistance in pathogenic fungi.
    Perea S; Patterson TF
    Clin Infect Dis; 2002 Nov; 35(9):1073-80. PubMed ID: 12384841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic Antifungal Agents: Current Status and Projected Future Developments.
    Seyedmousavi S; Rafati H; Ilkit M; Tolooe A; Hedayati MT; Verweij P
    Methods Mol Biol; 2017; 1508():107-139. PubMed ID: 27837500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antifungal susceptibility patterns of a global collection of fungal isolates: results of the SENTRY Antifungal Surveillance Program (2013).
    Castanheira M; Messer SA; Rhomberg PR; Pfaller MA
    Diagn Microbiol Infect Dis; 2016 Jun; 85(2):200-4. PubMed ID: 27061369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The fungal resistome: a risk and an opportunity for the development of novel antifungal therapies.
    Reales-Calderón JA; Molero G; Gil C; Martínez JL
    Future Med Chem; 2016 Aug; 8(12):1503-20. PubMed ID: 27485839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antifungal susceptibilities of Candida sp. in New Zealand.
    Hill PC; Rogers K; McKinney WP; Morris AJ; Holland DJ
    N Z Med J; 2001 Nov; 114(1144):528-9. PubMed ID: 11795573
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.